Inhibitors of glycogen synthase 3 kinase
Patent
·
OSTI ID:873412
- Oakland, CA
- Palo Alto, CA
- Berkeley, CA
- Victoria, AU
Compounds of formula 1: ##STR1## wherein R.sub.1 is alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl, substituted with 0-3 substituents selected from lower alkyl, halo, hydroxy, lower alkoxy, amino, lower alkyl-amino, and nitro; R.sub.2 is hydroxy, amino, or lower alkoxy; R.sub.3 is H, lower alkyl, lower acyl, lower alkoxy-acyl, or amnino-acyl; R.sub.4 is H or lower alkyl; and pharmaceutically acceptable salts and esters thereof; are effective inhibitors of GSK3.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA
- DOE Contract Number:
- AC03-76SF00098
- Assignee:
- Chiron Corporation (Emeryville, CA)
- Patent Number(s):
- US 6153618
- OSTI ID:
- 873412
- Country of Publication:
- United States
- Language:
- English
Similar Records
Inhibitors of glycogen synthase 3 kinase
Boron-based dual imaging probes, compositions and methods for rapid aqueous F-18 labeling, and imaging methods using same
Functionalized polyfluorenes for use in optoelectronic devices
Patent
·
Tue May 30 00:00:00 EDT 2006
·
OSTI ID:1175761
Boron-based dual imaging probes, compositions and methods for rapid aqueous F-18 labeling, and imaging methods using same
Patent
·
Tue Jun 05 00:00:00 EDT 2018
·
OSTI ID:1457028
Functionalized polyfluorenes for use in optoelectronic devices
Patent
·
Mon Nov 07 23:00:00 EST 2011
·
OSTI ID:1033606
Related Subjects
/514/999/
0-3
acceptable
acceptable salt
acyl
alkoxy
alkoxy-acyl
alkyl
alkyl-amino
amino
amnino-acyl
aralkyl
aryl
compounds
cycloalkyl
effective
esters
formula
glycogen
gsk3
halo
heteroaralkyl
heteroaryl
hydroxy
inhibitors
kinase
nitro
pharmaceutically
pharmaceutically acceptable
salts
selected
str1
substituents
substituents selected
substituted
synthase
0-3
acceptable
acceptable salt
acyl
alkoxy
alkoxy-acyl
alkyl
alkyl-amino
amino
amnino-acyl
aralkyl
aryl
compounds
cycloalkyl
effective
esters
formula
glycogen
gsk3
halo
heteroaralkyl
heteroaryl
hydroxy
inhibitors
kinase
nitro
pharmaceutically
pharmaceutically acceptable
salts
selected
str1
substituents
substituents selected
substituted
synthase